The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy
Pedro Bargão Santos(Hospital Prof. Dr. Fernando Fonseca), Rui Henrique(Universidade do Porto), Ana Félix(IPO Porto), Cármen Jerónimo(Universidade do Porto), Rita Manso(Hospital Prof. Dr. Fernando Fonseca), Beatriz Lourenço(Instituto Português de Oncologia Francisco Gentil), João Lobo(Universidade do Porto), José Pedro Sequeira(Instituto Português de Oncologia Francisco Gentil), João Costa(Instituto Português de Oncologia Francisco Gentil), Fernanda Silva(Universidade Nova de Lisboa), Hitendra H.R. Patel(St George's Hospital)
Cited by 6
Related Papers
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167
Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
|International Journal of Molecular Sciences|2019|141
Data Sharing Under the General Data Protection Regulation
|Hypertension|2021|136
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
|Nature Reviews Urology|2020|112
<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma
|Histopathology|2022|112